Search clinical trials for: Eplerenone

Total 121 results

Biolab Sanus Farmaceutica

Withdrawn

Pharmacokinetics of Eplerenone Tablet

Healthy Volunteers
Tufts Medical Center

Completed

Eplerenone for Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

United States
Vanderbilt University Medical Center
National Center for Research Resources (NCRR)

Completed

Diurnal Variation of Plasminogen Activator Inhibitor-1

Metabolic Syndrome X

United States
Darnitsa Pharmaceutical Company
ACDIMA Biocenter

Completed

Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Pr. Nicolas GIRERD

Recruiting

The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients. (EVATRAN)

Kidney Transplantation for More Than One Year | Patients With a Kidney Transplantation on Cyclosporine

France
University of Cincinnati

Withdrawn

Eplerenone as a Supplement to Epidural Steroid Injections

Low Back Pain | Sciatic Radiculopathy | Degenerative Intervertebral Discs

United States
Subha Raman
Ballou Skies

Completed

Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy (E-SCAR DMD)

Duchenne Muscular Dystrophy

United States
Semmelweis University

Completed

Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population

Chronic Central Serous Chorioretinopathy

Hungary
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity

Healthy Volunteers

United States
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Effect of Eplerenone on Novel Biomarkers of Mineralocorticoid Receptor Activation (ENOVA) (ENOVA)

Hypertension

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Cardiometabolic Effects of Eplerenone in HIV Infection

Hepatic Steatosis | Cardiac Steatosis

United States
Daiichi Sankyo, Inc.

Completed

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

Essential Hypertension

Japan
Poznan University of Medical Sciences

Completed

Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy

Obstructive Sleep Apnea | Left Ventricular Hypertrophy | Hypertension,Essential
Biolab Sanus Farmaceutica

Withdrawn

Pharmacokinetics Study of Eplerenone Coated Tablets

Healthy Subjects | Pharmacokinetics | Fasting

Brazil
Erasmus Medical Center
Pfizer; Dutch Kidney Foundation

Unknown

Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.

Hypertension | Hyperaldosteronism

Netherlands
Massachusetts General Hospital

Completed

Eplerenone in HIV Associated Abdominal Fat Accumulation

HIV

United States
McMaster University
Canadian Institutes of Health Research (CIHR)

Completed

Eplerenone in Hemodialysis Trial (PHASE)

Hemodialysis | End Stage Renal Disease

Canada
University of Erlangen-Nürnberg Medical School

Completed

Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension

Essential Hypertension

Germany
Wills Eye
Mid Atlantic Retina

Completed

Eplerenone for the Treatment of Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

United States
Radboud University Medical Center

Completed

Eplerenone, ACE Inhibition and Albuminuria

Diabetic Nephropathy

Netherlands
Bayer

Completed

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone (ARTS-HF)

Heart Failure

France, Taiwan, United States, Turkey, Spain, Greece, Portugal, Germany, Canada, Austria, Czechia, Denmark, Israel, Korea, Republic of, Poland, South Africa, Sweden, Bulgaria, Italy, Finland, Hungary, Lithuania, Netherlands, Australia, ...
NHS National Waiting Times Centre Board
Abbott; British Heart Foundation

Recruiting

Stratified Medicine of Eplerenone in Acute MI/Injury (StratMed-MINOCA)

Myocardial Injury | Myocardial Infarction, Acute | Myocardial Infarction With Nonobstructive Coronary Arteries

United Kingdom
Novartis
Integrium; Great Lakes Drug Development, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension

Hypertension

United States, Iceland
Medical University of Vienna

Unknown

Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation

Liver Transplantation | Osteoporosis

Austria
Beni-Suef University

Unknown

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

Diabetic Nephropathy Type 2 | Microalbuminuria Due to Type 2 Diabetes Mellitus

Egypt
Novartis Pharmaceuticals

Completed

A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension

Essential Hypertension

United States
Göteborg University
Karolinska Institutet; Umeå University

Recruiting

Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment (UPA-MEST)

Primary Hyperaldosteronism Due to Adrenal Adenoma

Sweden
University of Mississippi Medical Center

Terminated

A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives

Hypertension | Obesity

United States
Janssen-Cilag International NV

Completed

A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adults

Healthy

Germany
AstraZeneca

Completed

A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects

Healthy Subjects | Pharmacodynamics

United Kingdom
Sandoz

Completed

Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions

Hypertension
Neurotrope Bioscience, Inc.

Completed

A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease

Alzheimer's Disease

United States
Vanderbilt University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brigham...

Completed

Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas

Primary Aldosteronism

United States
Federico II University

Completed

Eplerenone Versus PDT: Comparative Study by OCTA

Central Serous Chorioretinopathy
Sandoz

Completed

Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions

Hypertension
Brigham and Women's Hospital
National Institutes of Health (NIH)

Completed

Aldosterone and Vascular Disease in Diabetes Mellitus

Diabetes Mellitus | Albuminuria | Endothelial Dysfunction

United States
Bayer

Completed

Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862

Clinical Pharmacology

Germany
Pfizer

Terminated

A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension

Hypertension

Taiwan
Elpen Pharmaceutical Co. Inc.

Not yet recruiting

TorasEmide Induced Effect on Quality of Life and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone. (ESTIA)

Chronic Heart Failure
Northwestern University

Withdrawn

Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus

Diabetes Mellitus | HF - Heart Failure

United States
Hippocration General Hospital
National and Kapodistrian University of Athens

Recruiting

The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.

Obesity | Primary Hypertension

Greece
Brigham and Women's Hospital

Completed

MR Antagonist and STRIATIN

Hypertension | Genetics Hypertension

United States
Hippocration General Hospital

Unknown

Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients (HEVRO)

Hypertension | Obesity

Greece
Wagner Macula & Retina Center
ThromboGenics

Terminated

Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists) (TOTEM)

Vitreomacular Traction | Subretinal Edema

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure (REMODEL)

Heart Failure, Congestive

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years

Hypertension

United States, Russian Federation, India
Brigham and Women's Hospital

Completed

Effect of Eplerenone on Postprandial Inflammatory Response in Healthy Adults

Systemic Proinflammatory State

United States
Royal Brompton & Harefield NHS Foundation Trust

Completed

CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone

Cardiomyopathy

United Kingdom
Medical University of Vienna

Unknown

The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)

CKD II-III

Austria
North Florida Foundation for Research and Education
Malcom Randall VA Medical Center

Completed

Pressure Assessment to Improve Outcomes After TAVR: a Registry

Quality of Life | Hypertension | Heart Failure With Preserved Ejection Fraction | Aortic Stenosis, Calcific

United States

Search clinical trials for: Eplerenone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations